Literature DB >> 29752523

Limiting consumption in tuberculosis: current concepts in anti-tuberculosis treatment in the critically ill patient.

Mervyn Mer1, Alimuddin Zumla2, Martin W Dünser3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29752523     DOI： 10.1007/s00134-018-5161-5

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  12 in total

1.  Antibiotic administration in the critically ill - in need of intensive care!

Authors:  M Mer; J Lipman
Journal:  S Afr Med J       Date:  2015-05

2.  Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial.

Authors:  Rovina Ruslami; A Rizal Ganiem; Sofiati Dian; Lika Apriani; Tri Hanggono Achmad; Andre J van der Ven; George Borm; Rob E Aarnoutse; Reinout van Crevel
Journal:  Lancet Infect Dis       Date:  2012-10-25       Impact factor: 25.071

Review 3.  Tuberculosis.

Authors:  Alimuddin Zumla; Mario Raviglione; Richard Hafner; C Fordham von Reyn
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

Review 4.  Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Karen R Steingart; Ian Schiller; David J Horne; Madhukar Pai; Catharina C Boehme; Nandini Dendukuri
Journal:  Cochrane Database Syst Rev       Date:  2014-01-21

Review 5.  The critically ill patient with tuberculosis in intensive care: Clinical presentations, management and infection control.

Authors:  Akaninyene Otu; Madiha Hashmi; Ahmed M Mukhtar; Arthur Kwizera; Simon Tiberi; Bruce Macrae; Alimudin Zumla; Martin W Dünser; Mervyn Mer
Journal:  J Crit Care       Date:  2018-03-13       Impact factor: 3.425

6.  Mycobacterium tuberculosis septic shock.

Authors:  Shravan Kethireddy; R Bruce Light; Yazdan Mirzanejad; Dennis Maki; Yaseen Arabi; Stephen Lapinsky; David Simon; Aseem Kumar; Joseph E Parrillo; Anand Kumar
Journal:  Chest       Date:  2013-08       Impact factor: 9.410

7.  High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial.

Authors:  Martin J Boeree; Norbert Heinrich; Rob Aarnoutse; Andreas H Diacon; Rodney Dawson; Sunita Rehal; Gibson S Kibiki; Gavin Churchyard; Ian Sanne; Nyanda E Ntinginya; Lilian T Minja; Robert D Hunt; Salome Charalambous; Madeleine Hanekom; Hadija H Semvua; Stellah G Mpagama; Christina Manyama; Bariki Mtafya; Klaus Reither; Robert S Wallis; Amour Venter; Kim Narunsky; Anka Mekota; Sonja Henne; Angela Colbers; Georgette Plemper van Balen; Stephen H Gillespie; Patrick P J Phillips; Michael Hoelscher
Journal:  Lancet Infect Dis       Date:  2016-10-26       Impact factor: 25.071

8.  Drug Concentration Thresholds Predictive of Therapy Failure and Death in Children With Tuberculosis: Bread Crumb Trails in Random Forests.

Authors:  Soumya Swaminathan; Jotam G Pasipanodya; Geetha Ramachandran; A K Hemanth Kumar; Shashikant Srivastava; Devyani Deshpande; Eric Nuermberger; Tawanda Gumbo
Journal:  Clin Infect Dis       Date:  2016-11-01       Impact factor: 9.079

9.  Intensified Antituberculosis Therapy in Adults with Tuberculous Meningitis.

Authors:  A Dorothee Heemskerk; Nguyen D Bang; Nguyen T H Mai; Tran T H Chau; Nguyen H Phu; Pham P Loc; Nguyen V V Chau; Tran T Hien; Nguyen H Dung; Nguyen T N Lan; Nguyen H Lan; Nguyen N Lan; Le T Phong; Nguyen N Vien; Nguyen Q Hien; Nguyen T B Yen; Dang T M Ha; Jeremy N Day; Maxine Caws; Laura Merson; Tran T V Thinh; Marcel Wolbers; Guy E Thwaites; Jeremy J Farrar
Journal:  N Engl J Med       Date:  2016-01-14       Impact factor: 91.245

10.  Empirical use of fluoroquinolones improves the survival of critically ill patients with tuberculosis mimicking severe pneumonia.

Authors:  Yu-Tzu Tseng; Yu-Chung Chuang; Chin-Chung Shu; Chien-Ching Hung; Chiung-Fang Hsu; Jann-Yuan Wang
Journal:  Crit Care       Date:  2012-10-25       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.